https://www.selleckchem.com/products/esi-09.html
Results reflected a gap in terms of full coverage of key impacted areas from a patient's perspective. Methodological issues identified in this review related to scoring of instruments require careful consideration, as these challenges may limit the complete assessment of drug benefits. Selection of PRO measures aligned with the expected treatment benefit of a drug in a clinical trial should reflect patients' perspective holistically.Exacerbations of chronic obstructive pulmonary disease (COPD) are currently diagnosed based on changes in
Like
Comment
Share
